7908.T
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥11.14 billion, representing nearly half of its total assets. Its current ratio of 7.32 indicates a robust ability to meet short-term obligations, and the debt-to-equity ratio of 0.0 suggests no leverage, which is uncommon for capital-intensive industries like chemicals. The price-to-book ratio of 0.54 and price-to-tangible-book ratio of 0.54 indicate that the company is trading at a discount to its book value, potentially signaling undervaluation or asset-heavy operations.
Profitability metrics show a return on equity (ROE) of 2.98% and a return on assets (ROA) of 2.43%, both below the typical thresholds for high-performing chemical firms. The operating margin, calculated as operating income of ¥946 million on revenue of ¥10.55 billion, is approximately 8.97%, which is in line with the industry median of 9.0%. However, the net margin of 5.36% is slightly below the median of 5.5%, indicating some inefficiencies in cost control or pricing power.
The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases exposure to regional economic downturns or supply chain disruptions.
Looking ahead, the company is projected to maintain stable revenue growth, with a year-over-year increase of 2.1% in the current fiscal year and a 1.8% increase in the following year. These modest growth rates are in line with the industry's conservative expansion outlook, driven by steady demand in industrial markets and limited new capacity additions.
Risk factors include the potential for regulatory changes in the chemical industry, particularly in environmental and safety standards, which could increase compliance costs. The company has no immediate dilution risks, as both basic and diluted shares outstanding are identical, and no recent equity issuance or shelf registration activity has been reported. The absence of leverage also reduces credit risk, but the company's low ROE and ROA suggest that it is not generating strong returns relative to its capital base.
Recent filings and transcripts indicate no major strategic shifts or operational disruptions. The company continues to focus on cost optimization and operational efficiency, with capital expenditures of ¥265 million in the latest period, primarily directed toward maintenance and minor upgrades.
- The company has a strong liquidity position with a current ratio of 7.32 and no debt, but its profitability metrics are below industry medians.
- The price-to-book ratio of 0.54 suggests the company is undervalued relative to its book value.
- Revenue is concentrated in a single business segment, increasing exposure to market-specific risks.
- The company is projected to grow revenue by 2.1% in the current fiscal year and 1.8% in the next, in line with industry trends.
- No immediate dilution or liquidity risks are present, but the company's ROE and ROA are suboptimal for a capital-intensive industry.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 7908.T Market data — financials · 2026-05-27
- Kimoto Co Ltd Market data — analyst estimates · 2026-05-27